Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Sipes directs CDER Regulatory Policy; non-HFC propellant in Dr. Smith’s sprays; Bayer prioritizes health care investment; EMA oversight switch criticized; marketing, development changes At GNC; Pharmavite hires Kellogg, NBTY execs; and ‘Turtle Power’ for Colgate Kids Mouthwash.
You may also be interested in...
People In Brief: Maves at USP, Toll at Pharmavite, Lacik heads Reckitt North America
Maves is USP’s development SVP; Pharmavite takes on Toll as sales exec; Lacik shifts to head Reckitt North America; Rainbow Light adds marketing and sales VPs; Lelinski heads Walgreens health and wellness; more People In Brief.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.